Want to see TGTX full AI Analyst Report?
TG Therapeutics (TGTX) Hedge Fund Trading Activity
2,169 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 24.5K Shares Last Quarter
Hedge Fund Holdings in TGTX
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
| Hussman Strategic Advisors Inc | New | 100.00% | $2,884,350 | 0.66% | |||
| Blackstone Inc. | New | 100.00% | $406,831 | <0.01% | |||
| Bridgewater Associates, LP | Added | 38.05% | $23,618,926 | 0.10% | |||
| Woodline Partners LP | Not Changed | 0.00% | $39,309,570 | 0.12% | |||
| Gotham Asset Management LLC | Not Changed | 0.00% | $2,799,138 | 0.03% | |||
| Caxton Associates LP | Not Changed | 0.00% | $909,642 | 0.03% | |||
| Reduced | -0.91% | $1,211,429,472 | 0.02% |
FAQ
Which hedge funds hold TG Therapeutics?
The hedge funds that hold the most shares in TG Therapeutics are BlackRock, Inc., Stephen A. Schwarzman and Ray Dalio.
Are hedge funds buying or selling TGTX?
In the last quarter hedge funds have Decreased their holdings in TG Therapeutics by 24.5K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in TG Therapeutics stock?
Warren Buffet currently does not own shares in TG Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
